RARE on the Road in Salt Lake City, UT
June 18, 2018
Please join us and Global Genes on Saturday, June 30th for RARE on the Road Rare Disease Leadership Tour in Salt Lake City, Utah. This conference will educate rare disease patients, caregivers and other advocates through collaboration in an interactive and engaging environment.
A limited number of $150 travel stipends are available for rare disease patients and caregivers who otherwise would not be able to attend. Please apply here. REMINDER: the deadline to apply for a Salt Lake City travel stipend is May 31st.
Whether you are new to the rare disease community or a seasoned veteran, this full day workshop will help you become a more effective advocate. Topics include:
- Being Seen and Heard: Social Media Strategies to Click and Connect, presented by the Mayo Clinic.
- What’s on the Legislative Road Ahead? Accelerating Change in the Rare Disease Community.
- Detours to Destinations: Navigating Your Rare Disease Landscape.
Join us for this event at the Intermountain Primary Children’s Hospital from 8:30 a.m. through 4:30 p.m. Breakfast, a networking lunch and a t-shirt are included. Sample agenda is available here.
Unable to attend but want to ensure your patient community is present? Let us know and we can provide you with shareable materials to help spread the word! For more information, please visit www.RARETour.org or email lcundiff@everylifefoundation.org.
Thank you to the sponsors of RARE on the Road.
For information on additional sponsorship opportunities, please contact Carol Kennedy at ckennedy@everylifefoundation.org.
Recent News
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
- KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging
- Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
- Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
- Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
- Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology